financetom
Business
financetom
/
Business
/
Johnson Controls Dips Over 6% After Q2 Earnings - Here's Why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Johnson Controls Dips Over 6% After Q2 Earnings - Here's Why
May 1, 2024 9:30 AM

Johnson Controls International Plc ( JCI ) shares are trading lower on Wednesday.

The company reported second-quarter adjusted earnings per share of 78 cents, beating the street view of 75 cents. 

Quarterly sales of $6.699 billion missed the street view of $6.72 billion.

Reported sales in the quarter under review were flat versus prior year and increased 1% organically.

The company recorded a pre-tax charge of $750 million related to a settlement with a nationwide class of public water systems concerning the use of Aqueous Film Forming Foam manufactured and sold by a company subsidiary.

Quarterly orders grew 12% organically year-over-year, with a building solutions backlog of $12.6 billion, up 10% organically year-over-year.

Building Solutions North America segment EBITA margin of 13.6% expanded 110 basis points versus the prior year, led by higher margin backlog conversion and continued growth in Services.

Outlook: Johnson Controls ( JCI ) expects third-quarter adjusted EPS before special items of ~$1.05 to $1.10 versus the $1.11 estimate.

The company maintains full-year adjusted EPS before special items of ~$3.60-$3.75 versus the $3.59 estimate.

Regarding sales outlook, Johnson Controls ( JCI ) projects organic revenue to be up by low single-digit year over year in the third quarter, while the company sees organic revenue growth up by mid-single-digit year-over-year for the full year.

Price Action: JCI shares are trading lower by 6.65% to $60.73 at last check Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vanda Pharmaceuticals, AnaptysBio Sign Global License Agreement for Imsidolimab
Vanda Pharmaceuticals, AnaptysBio Sign Global License Agreement for Imsidolimab
Feb 3, 2025
08:36 AM EST, 02/03/2025 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) and AnaptysBio ( ANAB ) said Monday that they signed an agreement providing Vanda an exclusive global license to develop, manufacture, and commercialize imsidolimab. As part of the agreement, Vanda will make an upfront payment of $10 million and an additional $5 million for the existing drug supply...
Baxter's Kidney Care Segment Vantive Acquired by Carlyle Group
Baxter's Kidney Care Segment Vantive Acquired by Carlyle Group
Feb 3, 2025
08:33 AM EST, 02/03/2025 (MT Newswires) -- Baxter International's ( BAX ) former kidney care segment Vantive said Monday it has been acquired by funds managed by Carlyle Group ( CG ) . Vantive will now operate as an independent organ therapy company, it added. The deal was first announced by Baxter and Carlyle in August, under which Carlyle agreed...
Tyson Foods Posts Q1 Earnings: Protein Conscious Customers Drive Demand, CEO Calls It Best Quarter In 2 Years
Tyson Foods Posts Q1 Earnings: Protein Conscious Customers Drive Demand, CEO Calls It Best Quarter In 2 Years
Feb 3, 2025
Shares of Tyson Foods Inc ( TSN ) are trading higher after the first-quarter FY25 earnings result. The company reported first-quarter FY25 sales growth of 2.3% year-on-year to $13.62 billion, beating the analyst consensus estimate of $13.44 billion. Sales volume of Beef increased 5.6% Y/Y, Pork declined 0.4%, Chicken climbed 1.5%, and Prepared Foods dropped 3.2%. Gross profit surged 33%...
Former RTX CEO Gregory Hayes to step down as chairman
Former RTX CEO Gregory Hayes to step down as chairman
Feb 3, 2025
Feb 3 (Reuters) - Former RTX CEO Gregory Hayes will step down as executive chairman and member of the board, the aerospace and defense major said on Monday. Hayes will remain an employee of RTX as a special advisor to CEO Christopher Calio, who will take on the role of chairman of the board, the company said. The transition will...
Copyright 2023-2025 - www.financetom.com All Rights Reserved